Home The crystal structure of (E)-4-fluoro-N′-(1-(4-hydroxyphenyl)propylidene)benzohydrazide, C16H15FN2O2
Article Open Access

The crystal structure of (E)-4-fluoro-N′-(1-(4-hydroxyphenyl)propylidene)benzohydrazide, C16H15FN2O2

  • Juanjuan Wen , Langlang Liu , Wenqiang Tang ORCID logo EMAIL logo and Bin Liu ORCID logo
Published/Copyright: October 23, 2023

Abstract

C16H15FN2O2, orthorhombic, P212121 (no. 19), a = 7.2516(6) Å, b = 11.3780(9) Å, c = 17.1177(13) Å, V = 1412.36(19) Å3, Z = 4, R gt (F) = 0.0498, wR ref (F2) = 0.1201, T = 293 K.

CCDC no.: 2301106

The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Colorless block
Size: 0.32 × 0.25 × 0.22 mm
Wavelength: Mo Kα radiation (0.71073 Å)
μ: 0.10 mm−1
Diffractometer, scan mode:

θmax, completeness:
SuperNova, ω

29.2°, >99 %
N(hkl)measured, N(hkl)unique, Rint: 4708, 2860, 0.016
Criterion for Iobs, N(hkl)gt: Iobs > 2 σ(Iobs), 2160
N(param)refined: 192
Programs: CrysAlisPRO [1], SHELX [2, 3], Olex2 [4]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z Uiso*/Ueq
C1 0.4179 (4) 0.5129 (2) 0.14129 (18) 0.0378 (7)
C2 0.4952 (4) 0.4202 (3) 0.18177 (18) 0.0418 (8)
H2A 0.546372 0.357113 0.154920 0.050*
C3 0.4959 (5) 0.4220 (3) 0.26259 (18) 0.0423 (8)
H3 0.546971 0.358864 0.289482 0.051*
C4 0.4223 (4) 0.5156 (2) 0.30491 (17) 0.0372 (7)
C5 0.3438 (4) 0.6076 (3) 0.26239 (18) 0.0410 (7)
H5 0.292256 0.670936 0.288907 0.049*
C6 0.3412 (4) 0.6064 (3) 0.18199 (19) 0.0435 (8)
H6 0.287755 0.668473 0.154834 0.052*
C7 0.4290 (5) 0.5198 (3) 0.39095 (17) 0.0390 (7)
C8 0.4582 (5) 0.4076 (3) 0.43688 (19) 0.0489 (8)
H8A 0.424803 0.341036 0.404390 0.059*
H8B 0.376914 0.407758 0.481886 0.059*
C9 0.6562 (6) 0.3924 (4) 0.4646 (2) 0.0710 (12)
H9A 0.736559 0.386673 0.420201 0.107*
H9B 0.665753 0.322066 0.495323 0.107*
H9C 0.691194 0.458888 0.495791 0.107*
C10 0.4252 (5) 0.7362 (3) 0.53709 (17) 0.0410 (7)
C11 0.4259 (4) 0.7309 (3) 0.62433 (16) 0.0366 (7)
C12 0.5028 (5) 0.6387 (3) 0.66628 (19) 0.0462 (8)
H12 0.557782 0.576515 0.639811 0.055*
C13 0.4983 (5) 0.6384 (3) 0.7468 (2) 0.0499 (8)
H13 0.548701 0.576391 0.775074 0.060*
C14 0.4180 (5) 0.7314 (3) 0.78400 (18) 0.0467 (8)
C15 0.3408 (5) 0.8241 (3) 0.7453 (2) 0.0483 (9)
H15 0.286070 0.885714 0.772458 0.058*
C16 0.3465 (4) 0.8238 (3) 0.66471 (19) 0.0431 (8)
H16 0.296476 0.886608 0.637130 0.052*
F1 0.4154 (3) 0.7316 (2) 0.86353 (11) 0.0733 (7)
N1 0.4175 (4) 0.6235 (2) 0.42101 (14) 0.0411 (6)
N2 0.4213 (4) 0.6301 (2) 0.50161 (14) 0.0437 (6)
H2 0.421044 0.566907 0.529132 0.052*
O1 0.4081 (4) 0.51687 (19) 0.06185 (12) 0.0533 (6)
H1 0.457084 0.458080 0.043487 0.080*
O2 0.4244 (4) 0.82914 (19) 0.50187 (13) 0.0633 (7)

1 Source of materials

The synthesis and crystallization of the title compound were conducted following established laboratory protocols. In a 100 mL round-bottom flask, equipped with a stir bar and rubber septum, 4-fluorobenzohydrazide (0.15 g, 1 mmol) and 4-hydroxypropiophenone (0.15 g, 1 mmol) were combined with 5 drops of glacial acetic acid. To this mixture, 25 mL of absolute alcohol was added, and the resulting solution was stirred for 10 min at 50 °C. The stirring was continued for an additional 5 h to allow completion of the desired reactions. Subsequently, the solvent was evaporated to dryness using a rotary evaporator, yielding the crude product. The crude product was dissolved in a minimal amount of hot ethanol under controlled heating conditions, and the solution was gradually cooled to room temperature. During this cooling process crystal formed.

2 Experimental details

The crystal structure was solved in SHELXT [2] and refined in SHELXL [3]. The crystal structure was visually represented using the OLEX2 software package [4].

3 Comment

The benzohydrazide moiety has demonstrated its versatility in the development of biologically active compounds, establishing itself as a promising structural motif for drug discovery [5]. Previous single crystal structure studies have revealed that these compounds can exhibit either cis or trans conformation around the C=N double bond, with intramolecular hydrogen bond interactions occurring [6], [7], [8], [9]. In this study, we present a crystal structure, which exhibits a hydrogen bonding network involving the hydroxy group and hydrazide group.

The compound’s molecular configuration demonstrates an E conformation with regards to the C7=N1 bond, and exhibits torsion as evidenced by a dihedral angle of 56.7° between the two aryl rings. Within the crystal structure, intermolecular interactions are formed via O1–H1⋯O2 hydrogen bonds, arranging the molecules into parallel sheets aligned with the bc plane. Supplementary π⋯π interactions contribute to the formation of a three-dimensional network. All bond lengths fall within typical ranges and are consistent with those reported for similar compounds [10], [11], [12], [13], [14].


Corresponding author: Wenqiang Tang, Xianyang Key Laboratory of Molecular Imaging and Drug Synthesis, School of Pharmacy, Shaanxi Institute of International Trade & Commerce, Xianyang, Shaanxi, China, E-mail:

Funding source: the projects of Key Laboratory of Molecular Imaging and Drug Synthesis of Xianyang city

Award Identifier / Grant number: (2021QXNL-PT-0008)

Funding source: scientific research fund project of Shaanxi Institute of International Trade & Commerce

Award Identifier / Grant number: (SMXY202217)

Funding source: the scientific research plan project of Shaanxi provincial department of education

Award Identifier / Grant number: (23JK0328)

  1. Author contribution: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This work was financially supported by the projects of Key Laboratory of Molecular Imaging and Drug Synthesis of Xianyang city (2021QXNL-PT-0008), scientific research fund project of Shaanxi Institute of International Trade & Commerce (SMXY202217) and the scientific research plan project of Shaanxi provincial department of education (23JK0328).

  3. Competing interests: The authors declare no conflicts of interest regarding this article.

References

1. Rigaku Oxford Diffraction Ltd. CrysAlisPro; Rigaku Oxford Diffraction: Abingdon, Oxfordshire, England, 2023.Search in Google Scholar

2. Sheldrick, G. M. SHELXTL – integrated space-group and crystal-structure determination. Acta Crystallogr. 2015, A71, 3–8; https://doi.org/10.1107/s2053273314026370.Search in Google Scholar PubMed PubMed Central

3. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Search in Google Scholar

4. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Cryst. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Search in Google Scholar

5. Korkmaz, I. N., Türkeş, C., Demir, Y., Öztekin, A., Özdemir, H., Beydemir, Ş. Biological evaluation and in silico study of benzohydrazide derivatives as paraoxonase 1 inhibitors. J. Biochem. Mol. Toxic. 2022, 36, e23180; https://doi.org/10.1002/jbt.23180.Search in Google Scholar PubMed

6. Liu, B., Liu, H., Zhang, H., Di, Q., Zhang, H. Crystal engineering of a hydrazone molecule toward high elasticity and bright luminescence. J. Phys. Chem. Lett. 2020, 11, 9178–9183; https://doi.org/10.1021/acs.jpclett.0c02623.Search in Google Scholar PubMed

7. Alifu, Z., Nizhamu, M., Ablajan, K. Efficient synthesis of N′-benzylidene-2-hydroxymethylbenzohydrazides from the one-pot reaction of phthalide, hydrazine and aldehydes. Res. Chem. Intermediat. 2019, 45, 4779–4788; https://doi.org/10.1007/s11164-019-03863-8.Search in Google Scholar

8. Hao, Y.-M. Crystal structure of 2-chloro-N′-(2-methoxybenzylidene)benzohydrazide, C15H13ClN2O2. Z. Kristallogr. N. Cryst. Struct. 2011, 226, 11–12; https://doi.org/10.1524/ncrs.2011.0006.Search in Google Scholar

9. Ajayeoba, T. A., Woods, J. O., Ayeni, A. O., Ajayi, T. J., Akeem, R. A., Hosten, E. C., Akinyele, O. F. Synthesis, crystallographic, computational and molecular docking studies of new acetophenone-benzoylhydrazones. J. Mol. Struct. 2021, 1237, 130275; https://doi.org/10.1016/j.molstruc.2021.130275.Search in Google Scholar

10. Fun, H.-K., Horkaew, J., Chantrapromma, S. (E)-4-Hydroxy-N′-(3-hydroxy-4-methoxybenzylidene)benzohydrazide. Acta Crystallogr. 2011, E67, o2644–o2645; https://doi.org/10.1107/s1600536811036579.Search in Google Scholar PubMed PubMed Central

11. Xue, L.-W., Han, Y.-J., Zhao, G.-Q., Feng, Y.-X. Synthesis, characterization and crystal structures of N′-(5-bromo-2-hydroxybenzylidene)-2-fluorobenzohydrazide in unsolvated and monohydrate forms. J. Chem. Crystallogr. 2011, 41, 1599–1603; https://doi.org/10.1007/s10870-011-0146-z.Search in Google Scholar

12. Zhu, H.-Y. Synthesis, characterization, and crystal structures of 3-bromo-N′-(2-methoxybenzylidene)benzohydrazide and N′-(2-methoxybenzylidene)-3,4-methylenedioxybenzohydrazide. J. Chem. Crystallogr. 2011, 41, 1785–1789; https://doi.org/10.1007/s10870-011-9982-0.Search in Google Scholar

13. Ferraresi-Curotto, V., Echeverría, G. A., Piro, O. E., Pis-Diez, R., González-Baró, A. C. Structural, spectroscopic and DFT study of 4-methoxybenzohydrazide Schiff bases. A new series of polyfunctional ligands. Spectrochim. Acta, Part A 2015, 137, 692–700; https://doi.org/10.1016/j.saa.2014.08.095.Search in Google Scholar PubMed

14. Bai, Z.-C., Li, H., Liu, Y., Jing, Z.-L. N′-(2,4-Dichlorobenzylidene)-2-methoxybenzohydrazide. Acta Crystallogr. 2006, E62, o2295–o2296; https://doi.org/10.1107/s1600536806017053.Search in Google Scholar

Received: 2023-09-13
Accepted: 2023-10-13
Published Online: 2023-10-23
Published in Print: 2023-12-15

© 2023 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of bis(dimethylammonium) poly[(μ4-1,1′-(1,4-phenylenebis(methylene))bis(1H-pyrazole-3,5-dicarboxylato))-κ6O1, N2:O2:O3:O1′,N2′]nickel (II)], C22H26N6NiO8
  4. Hydrothermal synthesis and crystal structure of catena-poly[diaqua-bis(μ2-4-((pyridin-4-ylmethyl)amino)benzoato-κ2N:O)cobalt(II)] 4,4′-bipyridine – water (1/2/2)
  5. Crystal structure of (2S,3S,4S,5S, Z)-2,3,5,6-tetrakis(benzyloxy)-4-hydroxyhexanal oxime, C34H37NO6
  6. The crystal structure of hexakis(3-thiophenecarboxylato-κ2O,O″)-bis(1,10-phenanthroline-κ2N,N′) trimanganese(II), C54H34N4O12S6Mn3
  7. Crystal structure of catena-poly[(μ2-1,4-di(pyridin-4-yl)benzene-κ2N:N′)-(4-bromobenzoate-κ2O:O′)-(μ-2-bromobenzoate-κ2O,O′)nickel(II)] – water (2/1), C30H21Br2N2NiO4.5
  8. The crystal structure of poly[(μ3-1,3-phenylenedioxydiacetate-κ5O,O,O′,O″,O‴)-bis(4′-(4-(1H-imidazol-1-yl)phenyl)-4,2′:6′,4″-terpyridine-kN) cadmium(II)], C58H42CdN10O6
  9. The crystal structure of 5-chloro-6′-methyl-3-(4-(methylsulfonyl)phenyl)-[2,3′-bipyridin]-1′-ium 4-methylbenzenesulfonate
  10. Crystal structure of poly[(μ-benzoato)-(μ-cis-4–hydroxy-D-proline)lithium], C12H14LiNO5
  11. The crystal structure of catena-poly[aqua-(4-iodopyridine-2,6-dicarboxylato-κ3N,O,O)-copper(II)] monohydrate, C7H6NO6ICu
  12. The crystal structure of catena-[diaqua-(4-acetylphenoxyacetato-κ2O,O)-bis(4-acetylphenoxyacetato-κ3O,O:O)-dihydrate-lanthanum(III)]–4,4′-bipyridine (2/1), C35H35NO14La
  13. The crystal structure of catena-poly[(4-iodopyridine-2,6-dicarboxylato-κ4 O,N,O′,O′′)(4-imidazol-1-yl-pyridine-κN)copper(II)], C15H9N4O4ICu
  14. Crystal structure of polybis(μ 4-3,5-dicarboxylatopyrazol-1-yl)-bis(N,N-dimethylformamide)tri-copper(II)–acetonitrile (1/2), C20H22Cu3N8O10
  15. Crystal structure of poly[(μ2-5-hydroxy-isophthalato-κ4O,O′:O″,O‴)-(μ2-1,5-bis(imidazol-2-methyl)pentane-κ2N:N′)cadmium(II)], C21H24CdN4O5
  16. The crystal structure of poly[bis(μ2-1,4-bi(1-imidazolyl)benzene-κ2N:N′)bis(μ2-4,4′-methylenebis(3-hydroxy-2-naphthoate)-κ2O:O′)cobalt(II)], C35H24CoN4O6
  17. The crystal structure of a cobalt-vanadium-oxido hydrate
  18. The crystal structure of catena-poly[(μ 2-2H-1,2,3-triazole-4,5-dicarboxylato-κ 2 O, O′)-(μ 2-1,3-bis((1H-imidazol-1-yl)methyl)benzene-κ 2 N,N′) zinc(II)], C18H15N7O4Zn
  19. Crystal structure of poly[diaqua-(bis(m2-1,4-bis(imidazol-1-ylmethyl)benzene)-κ2N,N′-manganese] dichloride, C28H32MnN8O2Cl2
  20. The crystal structure of 9,10-dimethoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolino [3,2-a]isoquinolin-7-ium (E)-3-(4-nitrophenyl)acrylate pentahydrate, C29H34N2O13
  21. Crystal structure of poly[(μ6-ammoniotris(methylene))tris(hydrogen phosphonato)cadmium(II)], C3H10CdNO9P3
  22. Crystal structure of Zn2[(1,1′-(hexane-1,6-diyl)bis(3-(pyridin-3-yl)urea))·(H2O)2·(DMF)2·(SO4)2], C24H50N8O18S2Zn2
  23. The crystal structure of 2-anilino-1,4-naphthoquinone, C10H11NO2
  24. Crystal structure of (E)-2-(2-(4-(diethylamino)styryl)-1-ethyl-1,4-dihydroquinolin-4-yl) malononitrile, C26H26N4
  25. Crystal structure of ethyl 2-((2,6-dichloro-4-(cyanomethyl)phenyl) amino)benzoate, C17H14Cl2N2O2
  26. Synthesis and crystal structure of 2-(3-oxo-3-phenylpropyl)isoindoline-1,3-dione, C17H13NO3
  27. The crystal structure of bis(acetonitrile-κ1N)tetrakis(μ2-2,6-difluorobenzoato-κ2O:O′)rhodium(II) (Rh–Rh), C32H18F8O8N2Rh2
  28. The crystal structure of a new polymorph of 6-hydroxy-2-naphthoic acid, C11H8O3
  29. The crystal structure of [(8-carboxymethoxy-quinoline-2-carboxylate-κ4N,O,O,O)-2,2′-bipyridine-κ2N-copper(II)] tetrahydrate, C22H23N3O9Cu
  30. The crystal structure of ethyl 4-hydroxy-2-(4-methoxyphenyl)-5-oxo-1-(2-oxo-2H-chromen-6-yl)-2,5-dihydro-1H-pyrrole-3-carboxylate, C23H19NO7
  31. Crystal structure of 7-hydroxy-3,4-dihydronaphthalen-1(2H)-one, C10H10O2
  32. Crystal structure of bis(tetrapropylammonium) dodecacarbonyltetratelluridotetraferrate(2-), (Pr4N)2[Fe4Te4(CO)12]
  33. The crystal structure of poly[bis(μ2−3−aminopyridine−4−carboxylatoκ2N:O)Zinc(II)], [Zn(C6H5N2O2)2] n
  34. The crystal structure of methyl 5-nitro-2-(tosyloxy)benzoate, C15H13NO7S
  35. The crystal structure of 18-crown-6 ― tetraaqua-dichlorido-di-μ2-chloridodicopper(II) (2/1), C12H32O10Cu2Cl4
  36. Crystal structure of 6,6a,7,8,9,10-hexahydro-5H-pyrazino [2,3-e]pyrido[1,2-a]pyrazine, C10H14N4
  37. Crystal structure of catena-poly-{diaqua-bis[μ-(((4-chlorophenyl)sulfonyl)glycinato-κO)](μ2-4, 4′-bipyridine-κ2N:N′)cobalt(II)} dihydrate, C26H30Cl2CoN4O12S2
  38. Crystal structure of bis{N′-[1,3-diphenylprop-2-en-1-ylidene]-N-phenylcarbamohydrazonothioato}zinc(II), C44H36N6S2Zn
  39. Crystal structure of tetraaqua-bis(((4-chlorophenyl)sulfonyl)glycinato-κO)cobalt(II) dihydrate, C16H26Cl2CoN2O14S2
  40. Crystal structure of 2-(5-phenyl-1-(quinolin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl)phenol, C24H19N3O
  41. Crystal structure of 2-((2-fluoro-4-(trifluoromethyl)phenyl)(hydroxy)methyl)-7-methoxy-3,4-dihydronaphthalen-1((2H))-one, C19H16F4O3
  42. Crystal structure of 2-amino-4-(2-fluoro-3-(trifluoromethyl)phenyl)-9-methoxy-1,4,5,6-tetrahydrobenzo[h]quinazolin-3-ium chloride, C20H18ClF4N3O
  43. Crystal structure of (2-phenylimino methylquinoline-κ 2 N,N′)-bis(1–phenylpyrazole-κ 2 C,N)-iridium(III) hexafluorophosphate, C34H26F6IrN6P
  44. Crystal structure of (3-hydroxy-4-methoxyphenyl)(pyrrolidin-1-yl)methanone, C12H15NO3
  45. The crystal structure of bis(trimethylsulfoxonium) catena-poly[µ2-hexabromido-indium(III)sodium(I)] C6H18O2S2NaInBr6
  46. Crystal structure of N-cyclopropyl-3-hydroxy-4-methoxybenzamide, C11H13NO3
  47. The crystal structure of (bis(benzimidazol-2-yl-methyl)amine-κ3N,N,N )-(dihydrogen L-malate-κ2O,O )copper(II) perchlorate dihydrate, CuC20H24ClN5O12
  48. Crystal structure of (1E,1′E)-4,4′-(9,9-diethyl-9H-fluorene-2,7-diyl)dibenzaldehyde dioxime, C31H28N2O2
  49. Crystal structure of diethyl 1,9-bis(4-fluorophenyl)-4,6-diphenylhexahydro-3H-2,7,3,5-(epimethanetriyliminomethanetriyl)cyclopenta [b]pyridine-3,7(2H)-dicarboxylate, C40H36F2N2O4
  50. Crystal structure of bis(benzene-1 carboxylato-O 3,5-carboxyl-κ1O)-[(5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′)nickel(II) ─ benzene-1,3,5-tricarboxylic acid ─ water (1/2/4), C52H66N4NiO28
  51. Crystal structure of 1,4-dibromo-2,5-bis(2-methoxyethoxy)benzene-1,4-diol, C12H16Br2O4
  52. Crystal structure of dicarbonyl[N,N′-(1,2-dimethyl-1,2-ethanediylidene)bis[2,6-bis(1-methylethyl)benzenamine]-N,N′]nickel(0), C30H40N2NiO2
  53. Crystal structure of 1,4-dibromo-2,5-bis(prop-2-yn-1-yloxy)benzene, C12H8Br2O2
  54. Crystal structure of O-(3-(benzo[d]thiazol-2-yl)naphthalen-2-yl) O-phenyl carbonothioate, C24H15NO2S2
  55. The crystal structure of (E)-4-fluoro-N′-(1-(4-hydroxyphenyl)propylidene)benzohydrazide, C16H15FN2O2
  56. Crystal structure of (E)-1-(benzo[d]thiazol-2-yl)-N-(4,5-dihydropyren-2-yl)methanimine, C24H16N2S
  57. Crystal structure of 3-((4-bromophenyl)thio)-1H-indole, C14H10BrNS
  58. Synthesis and crystal structure of 1-((7-hydroxy-3-(4-hydroxy-3-nitrophenyl)-4-oxo-4H-chromen-8-yl)methyl)piperidin-1-ium-4-carboxylate monohydrate, C22H22N2O9
  59. Synthesis and crystal structure of (3E,5S,10S,13S,14S,17Z)-17-ethylidene-10,13-dimethylhexadecahydro-3H-cyclopenta[α]phenanthren-3-one O-(methacryloyl) oxime, C50H74N2O4
  60. Crystal structure of the hydrogen storage active phase La12Mg46LiMn
  61. The crystal structure of the salt: 4-((1,3-dioxoisoindolin-2-yl)carbamoyl)pyridine-1-ium 2-carboxybenzoate, C14H10N3O3·C8H5O4
  62. Crystal structure of (2-(2-pyridine)-benzimidazole-κ2 N,N′)-bis(1-phenylpyrazole-κ2 C,N)iridium(III) hexafluorophosphate, C30H22F6IrN7P
  63. Crystal structure of dichlorido-bis[2-(2,4-difluorophenyl)pyridine-κ1N]platinum(II), C22H14Cl2F4N2Pt
  64. Crystal structure of (5R,8R,9R,10R,12R,13R,14R, 17S,17Z)-2-((3-fluoropyridin-4-yl)methylene)-12-hydroxy-4,4,8,10,14-pentamethyl-17-((R)-2,6,6-trimethyltetrahydro-2H-pyran-2-yl)hexadecahydro-3H-cyclopenta[a]phenanthren-3-one, C36H52FNO3
Downloaded on 7.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2023-0404/html
Scroll to top button